PA Consulting Group’s open innovation work has been profiled in The Times in an article dedicated to PA. The article discusses PA’s latest open innovation survey following a visit from Carol Lewis, business features editor at The Times, to PA’s Cambridge Technology Centre. Carol reports on some of the innovative work of PA consultants, who she describes as the "vanguards of scientific strategy".
The article goes on to give a description of PA’s work: “Scientists are working on a range of exciting and unusual innovations. One is developing semi-frozen drinks using a machine originally designed by an IVF company to freeze embryo cells, another scientist talks excitedly about high powered injection systems for delivering drugs and about smart phone applications to monitor medicine efficacy, two others grapple in a corridor with a state-of-the-art remote control hospital bed while a couple of their colleagues demonstrate a prototype ‘hydroxyl radical generator’ designed to kill airborne viruses and bacteria.”
Commenting on PA’s views on open innovation, Carol writes: "Open innovation is seen as the future modus operandi for the pharmaceutical industry," where research and development teams are needed to rein back operational costs whilst simultaneously dealing with depleted product pipelines and impending patent expiries.
The article also quotes PA’s Wil Schoenmakers, open innovation expert, extensively. Wil says: “Open innovation should drive costs down, not up, but they might have to make fundamental changes such as lay-off R&D scientists and spend more money outside the organisation.” Wil also points out that innovation scouts are not just 'lab rats' and they need to have business acumen and an appreciation of the commercial as well as technical aspects of the organisation and, most importantly, good people skills.
You can read the article in full here
To visit our pages on open innovation, click here